抗微生物药物诱导自身免疫性肝炎的汇总分析
被引量:2
摘要
自身免疫性肝炎(autoimmunehepatitis,AIH)是由异常的自身免疫反应介导的肝实质炎性反应性病变。一般认为是存在遗传易感性的个体在环境因素作用下激活针对肝脏抗原的特异性免疫应答反应。近年来,有报道多种药物如抗微生物药物、调脂药和干扰素等亦可引起AIH,
出处
《中华消化杂志》
CAS
CSCD
北大核心
2012年第11期767-769,共3页
Chinese Journal of Digestion
基金
天津医科大学重点学科基金(2009xk37)
参考文献16
-
1Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci, 2011,56:958-976.
-
2Hennes EM, Zeniya M, Czaja AJ,et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology, 2008, 48:169-176.
-
3Qiu D, Wang Q, Wang H, et al. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. J Hepatol, 2011,54:340-347.
-
4Abe M, Furukawa S, Takayama S, et al. Drug-induced hepatitis with autoimmune features during minoeyeline therapy. Intern Med, 2003,42:48 52.
-
5Bachmeyer C, Cadranel JF. Minocycline-induced lupus and autoimmune hepatitis: family autoimmune disorders as possible risk factors. Dermatology, 2002,205: 185-186.
-
6Bjornsson E, Talwalkar J, Treeprasertsuk S, et al. Druginduced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology, 2010,51 : 2040-2048.
-
7Chamberlain MC, Sehwarzenberg SJ, Akin EU, et al. Minocyeline-induced autoimmune hepatitis With subsequent cirrhosis. J Pediatr Gastroenterol Nutr, 2006,42 : 232-235.
-
8Ford TJ, Dillon JF. Minocycline hepatitis. Eur J Gastroenterol Hepatol, 2008,20 : 796-799.
-
9Ramakrishna J, Johnson AR, Banner BF. Long-term minocycline use for acne in healthy adolescents can cause severe autoimmune hepatitis. J Clin Gastroenterol, 2009,43: 787-790.
-
10Peedikayil MC, Dahhan TI, Al Ashgar HI. Nitrofurantoin- induced fulminant hepatitis mimicking autoimmune hepatitis. Ann Pharmacother, 2006,40 : 1888-1889.
二级参考文献3
-
1张福奎,贾继东.自身免疫性肝炎的诊断与治疗[J].中国实用内科杂志,2006,26(12):1849-1852. 被引量:13
-
2Albert J, Czaja MD. Diagnosis and therapy of autoimmune liver disease[J]. Med Clin North Am,1996,80(5):973.
-
3江宇泳.药物诱导的自身免疫性肝炎[J].药物不良反应杂志,2008,10(3):199-204. 被引量:10
同被引文献22
-
1Bonito AJ,Aloman C,Fiel MI,et al.Medullary thymic epithelial cell depletion leads to autoimmune hepatitis[J].J Clin Invest,2013,123(8):3510-3524.
-
2Weiler-Normann C,Sebode M,Lohse AW.Autoimmune hepatitis 2013and beyond[J].Minerva Gastroenterol Dietol,2013,59(2):133-141.
-
3Hoffman MS,Mitchell GS.Spinal 5-HT7receptors and protein kinase A constrain intermittent hypoxia-induced phrenic long-term facilitation[J].Neuroscience,2013,250:632-643.
-
4Boberg KM,Wisloff T,Kjollesdal KS,et al.Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid[J].Aliment Pharmacol Ther,2013,38(7):794-803.
-
5Wang Q,Qiu D,Ma X.Early normalization of aminotransferase predicts complete biochemical remission in autoimmune hepatitis patients[J].Aliment Pharmacol Ther,2011,34(1):107-109.
-
6Fujiwara K,Nakano M,Yasui S.Advanced histology and impaired liver regeneration are associated with disease severity in acute-onset autoimmune hepatitis[J].Histopathology,2011,58(5):693-704.
-
7Egawa H,Nakanuma Y,Maehara Y,et al.Disease recurrence plays a minor role as a cause for retransplantation after living-donor liver transplantation for primary biliary cirrhosis:A multicenter study in Japan[J].Hepatol Res,2013,43(5):502-507.
-
8Híndi M,Levy C,Couto CA,et al.Primary biliary cirrhosis is more severe in overweight patients[J].J Clin Gastroenterol,2013,47(3):28-32.
-
9Manns MP,Czaja AJ,Gorham JD,et al. Diagnosis and manage- ment of autoimmune heptitis[J]. Hepatology,2010,51 (6) :2193- 2213.
-
10Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis [J]- Hepatology,2010,51(2) : 660-678.
二级引证文献12
-
1尚佳,宁会彬.自身免疫性肝病重叠综合征的诊断及治疗现状[J].临床肝胆病杂志,2015,31(2):174-177. 被引量:2
-
2吴玲.自身免疫性肝炎临床特征及治疗[J].医学理论与实践,2016,29(4):472-473. 被引量:2
-
3李磊,李冰,丁惠国.熊去氧胆酸对不同原因胆汁淤积性肝病患者鼻胆管引流术后胆汁排泌的影响[J].临床肝胆病杂志,2016,32(3):522-525. 被引量:5
-
4魏华芳,周长玉.原发性胆汁性肝硬化/原发性硬化性胆管炎重叠综合征合并狼疮性脂膜炎1例报告[J].临床肝胆病杂志,2016,32(6):1169-1170. 被引量:2
-
5张臻英,王玉平,周永宁.原发性胆汁性胆管炎诊治进展[J].临床肝胆病杂志,2016,32(10):2016-2020. 被引量:2
-
6徐琼,张锋.疏肝利胆通络解毒方联合熊去氧胆酸治疗原发性胆汁性肝硬化的疗效分析[J].中国中医药科技,2016,23(6):724-726. 被引量:9
-
7郑金萍,赵英,张伯鹏.异甘草酸镁联合熊去氧胆酸治疗原发性胆汁性肝硬化的临床研究[J].世界中医药,2017,12(2):289-292. 被引量:18
-
8王美玲.原发性胆汁性肝硬化与病毒肝炎性肝硬化的临床超声诊断研究[J].中国医药指南,2017,15(22):165-166. 被引量:2
-
9张晓梅.熊去氧胆酸单药治疗原发性胆汁性肝硬化肝炎重叠综合征的临床研究[J].现代消化及介入诊疗,2017,22(4):487-489. 被引量:16
-
10王厚安.熊脱氧胆酸与泼尼松联合治疗自身免疫性肝炎的疗效观察[J].中国医药指南,2018,16(32):147-148. 被引量:1
-
1李树倩,周璐,张洁,罗莉丽,苏海燕,焦国慧,曹晓沧,刘文天,王邦茂.熊去氧胆酸联合免疫抑制剂治疗自身免疫性肝炎的疗效分析[J].中华消化杂志,2015,35(11):767-770. 被引量:10
-
2赵春燕.抗微生物药物相关的急性肝炎[J].传染病网络动态,2003(4):28-30.
-
3徐积恩.口服抗微生物药物治疗呼吸道感染的现状分析[J].医药导报,1992,11(3):13-16.
-
4卢璐,石虹,张顺财.30例老年药物性肝病的临床分析[J].老年医学与保健,2010,16(2):88-90. 被引量:4
-
5孙杨,罗娟,李敏丽,崔蓉,刘文斌,缪应雷.英夫利西单抗治疗炎症性肠病的临床分析[J].昆明医科大学学报,2015,36(2):147-149. 被引量:5
-
6康美玲.120例类风湿关节炎患者护理体会[J].吉林医学,2010,31(36):6882-6882. 被引量:1
-
7王火.社区获得性肺炎抗微生物药物的合理应用[J].武警医学院学报,2004,13(6):429-430. 被引量:3
-
8秦剑.药物性粒细胞减少及其治疗[J].中国医药导报,2009,6(28):154-155. 被引量:21
-
9刘永生,张靖华,时俊伟.抗微生物药物预防肾移植术后肺炎的临床观察[J].中华当代医学,2005,3(4):35-36.
-
10马红.社区获得性肺炎应用抗生素序贯疗法100例临床体会[J].青海医药杂志,2004,34(7):24-25.